Public Alert No. 0031/2020-Alert on Fake Hydroxychloroquine Medication in Circulation
, The National Agency for Food and Drug Administration and Control has been informed that the Chilean Institute of Public Health has issued a warning on the circulation of fake hydroxychloroquine sulphate-based medication tablets, Reumazine 200mg with Lot Number 0307620/F18705 and expiry date of March, 2022. The fake Reumazine 200mg is already in circulation in […]
Public Alert No. 0030/2020 – Warning on use of Tafrodol Manufactured by Deep Pharmaceutical, India
, The National Agency for Food and Drug Administration and Control (NAFDAC) alerts the members of the public against the use of a drug marketed on the internet under the brand name Tafrodol by Deep Pharmaceutical, Mumbai, Maharashtra, India. The active ingredients for Tafrodol declared by the manufacturer are Tapentadol Hcl 100mg and Carisoprodol 125mg […]
Public Alert No. 021/2020-The Protein Shoppe recalls Red-E Male Enhancement Tablets Due to the Presence of Undeclared Sildenafil
, The National Agency for Food and Drug Administration and Control has been informed that the Protein Shoppe, LLC has announced a voluntary recall of all lots of Red-E Male Enhancement Tablets. The recall was initiated after an FDA analysis found that the product contains undeclared sildenafil, a Phosphodiesterase-5 (PDE-5) inhibitor that is used in […]
Public Alert No. 028/2020- Boots Company PLC Recalls Boots Dermacare 1% w/w Hydrocortisone Ointment, EL (20) A/47 (Batch Number: IDD) due to the presence of Pseudomonas aeruginosa
, The National Agency for Food and Drug Administration and Control has been informed by the United Kingdom’s (UK) Medicine and Healthcare Product Regulatory Agency (MHRA) that Boots Company PLC has recalled Boots Dermacare 1% w/w Hydrocortisone Ointment, EL (20) A/47 (Batch Number: IDD) due to the presence of Pseudomonas aeruginosa. Boots Dermacare 1% w/w […]
Public Alert No. 027/2020-Distribution and Sale of Unregistered Daonil 5mg Tablets
, The National Agency for Food and Drug Administration and Control has been informed by Sanofi-Adventis Nigeria Limited on the distribution and sale of unregistered Daonil 5mg tablets (60×10) in Nigeria. Sanofi Adventis Nigeria is the marketing authorization holder for Daonil 5mg tablets (10×10) in Nigeria with NAFDAC registration number (NRN) 04-0744. The details of […]
Public Alert No: 026/2020-Alert on Petazone (Dexamethasone Injection) Batch Number 190314 Due to Unsatisfactory Report of Laboratory Analysis
, The National Agency for Food and Drug Administration and Control (NAFDAC) following an investigation on Petazone (Dexamethasone Injection) batch number 190314 sampled and analyzed the product. The result of laboratory analysis was observed to be unsatisfactory. The report of the analysis on the product established that the affected batch of the product failed sterility […]
Opening Address By Professor Mojisola Christianah Adeyeye Adeyeye At The Virtual Launch Of The Med Safety Mobile App For Adverse Drug Reactions Reporting In Nigeria
Keynote Speech By Prof. Adeyeye C. M Director General NAFDAC Virtual Launch Of The Med Safety Mobile App For Adverse Drug Reactions Reporting In Nigeria NAFDAC Head Quarters, Abuja. 4th November, 2020. The Honourable Minister of Health, Federal Republic of Nigeria, The Permanent Secretary, Federal Ministry of Health The Chairman, National Drug Safety Advisory Committee […]
Brief By Professor Mojisola Christiana Adeyeye At The Launching Of The Nigeria Pharmaceutical Traceability Strategy And Inauguration Of The Steering Committee For The Implementation Of The Traceability Strategy
, Brief By Prof. Adeyeye C. M Director General NAFDAC Nigeria Pharmaceutical Traceability Strategy And Inauguration Of The Steering Committee For The Implementation Of The Traceability Strategy Ministry’s Conference Room, 6th Floor FMOH, Federal Secretariat Complex, Abuja 8th October 2020. Protocol…., The Honourable Minister for Health, Ladies and Gentlemen, Safeguarding the health of the Nation […]
2020 Med Safety Week
, NAFDAC joins the Uppsala Monitoring Centre, international partners and other National Medicines Regulatory Authorities across the world to mark the 2020 Med Safety Week ………… Nigeria is one of the 79 countries participating in the 2020 annual med safety week organized by the WHO Collaborating Centre for International Drug Monitoring (Uppsala Monitoring Centre) in the week 2nd – 8th […]
Public Alert No. 025/2020-Alert on falsified Zinnat Suspension 125mg/5ml circulating in Nigeria
, The National Agency for Food and Drug Administration and Control has been informed by GlaxoSmithKline Pharmaceutical Nigeria Limited on the circulation of falsified Zinnat Suspension a brand of Cefuroxime Axetil Lot Number 349R in retail outlets in Nigeria. This lot number (349R) has been used on the genuinely manufactured Zinnat Suspension 125mg/5ml which expired […]
